Amundi Index Solutions - Amundi Index MSCI Europe UCITS ETF DR (USD) | CEU2Register to Unlock Ratings |
Performance History | 31/03/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | - | - | -3.3 | 13.0 | 5.8 | |
+/-Cat | - | - | 5.0 | 1.4 | 0.1 | |
+/-B’mrk | - | - | 1.2 | -0.2 | -0.4 | |
Category: Europe Large-Cap Blend Equity | ||||||
Category Benchmark: Morningstar DM Eur TME NR EUR |
Key Stats | ||
Closing Price 26/04/2024 | USD 97.64 | |
Day Change | 1.02% | |
Morningstar Category™ | Europe Large-Cap Blend Equity | |
Volume | 0 | |
Exchange | LONDON STOCK EXCHANGE, THE | |
ISIN | LU1437015735 | |
Fund Size (Mil) 26/04/2024 | EUR 3990.10 | |
Share Class Size (Mil) 26/04/2024 | EUR 1880.23 | |
Ongoing Charge 10/02/2023 | 0.15% |
Investment Objective: Amundi Index Solutions - Amundi Index MSCI Europe UCITS ETF DR (USD) | CEU2 |
To track the performance of MSCI Europe Index (the "Index"), and to minimize the tracking error between the net asset value of the sub-fund and the performance of the Index. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Isabelle Lafargue 07/09/2015 | ||
Inception Date 10/11/2016 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI Europe NR EUR | Morningstar DM Eur TME NR EUR |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Amundi Index Solutions - Amundi Index MSCI Europe UCITS ETF DR (USD) | CEU2 | 25/04/2024 |
|
|
Top 5 Holdings | Sector | % |
Novo Nordisk A/S Class B | Healthcare | 3.79 |
ASML Holding NV | Technology | 3.36 |
Nestle SA | Consumer Defensive | 2.52 |
Shell PLC | Energy | 2.20 |
AstraZeneca PLC | Healthcare | 2.18 |
Increase Decrease New since last portfolio | ||
Amundi Index Solutions - Amundi Index MSCI Europe UCITS ETF DR (USD) | CEU2 |